IMRAB Large Animal

Company: Boehringer Ingelheim Animal Health

Rabies Vaccine, Killed Virus

IMRAB Large Animal Indications

This product has been shown to be effective for the vaccination of healthy sheep, cattle and horses 12 weeks of age and older against rabies virus. The duration of immunity is at least 3 years for sheep, and at least 1 year for cattle and horses. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Directions and dosage: Shake well before use. Aseptically inject 2 mL (1 dose) subcutaneously or intramuscularly into healthy sheep, cattle and horses. Revaccinate cattle and horses annually; sheep 1 year after first vaccination, then every 3 years with a single dose.

Precautions

Store at 2-8°C (35-46°F). Do not freeze. Do not use chemicals to sterilize syringes and needles. Do not mix with other products. Use entire contents when first opened. Do not vaccinate food producing animals within 21 days prior to slaughter. This product has not been tested in pregnant animals. A transient local reaction may occur at the injection site following subcutaneous administration. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact a physician.

Preservatives: Gentamicin and thimerosal.

For use in animals only. Restricted to use by or under the direction of a veterinarian.

Manufactured by: Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601 USA

Tel: 1 (888) 637-4251

VLN/PCN 124/1905.20

Distributed in Canada by: Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

IMRAB^® is a registered trademark in the USA of Boehringer Ingelheim Animal Health USA Inc.

CPN: 1028341.0